Jose Ignacio Fernandez-Velasco

6PUBLICATIONS
57CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 28, 2026
Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.

Iván García de la Torre, Carlota García-Hoz, Fernando Martin-Moro

|Jul 29, 2025
Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.

Enric Monreal, José Ignacio Fernández-Velasco, Susana Sainz de la Maza

|Jan 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis.

Manuel Comabella, Agustín Pappolla, Enric Monreal

|Dec 17, 2024
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.

Raquel Sainz-Amo, Alexander Rodero-Romero, Enric Monreal

|Aug 05, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.

Enric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente

Pageof 1